4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-071172
Director sold 300 shares at $9.73 ($2,920)
- Director acquired 10,452 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Christian Waage Director | 2021-12-21 | Sale | −300 | $9.73 | $2,920 | 3,200 | D: show line 1 in the form |
| Christian Waage Director | 2021-12-22 | Grant or award | +10,452 | 13,652 | D: show line 2 in the form | ||
| Open-market sales · 300 sh · avg $9.73 · $2,920 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Christian Waage Director | 2021-12-22 | Grant or award · Stock Option (Right to Buy) | +20,903 | 20,903 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…